143.67
5.75 (4.17%)
| 前收盘价格 | 137.92 |
| 收盘价格 | 139.56 |
| 成交量 | 837,913 |
| 平均成交量 (3个月) | 364,795 |
| 市值 | 4,151,876,096 |
| 市盈率 (P/E TTM) | 34.45 |
| 预期市盈率 (P/E Forward) | 18.62 |
| 价格/销量 (P/S) | 12.36 |
| 股市价格/股市净资产 (P/B) | 4.05 |
| 52周波幅 | |
| 利润日期 | 4 Aug 2025 - 8 Aug 2025 |
| 营业毛利率 | 37.17% |
| 营业利益率 (TTM) | 41.03% |
| 稀释每股收益 (EPS TTM) | 4.17 |
| 季度收入增长率 (YOY) | 94.90% |
| 季度盈利增长率 (YOY) | 3,734.00% |
| 总债务/股东权益 (D/E MRQ) | 0.98% |
| 流动比率 (MRQ) | 9.65 |
| 营业现金流 (OCF TTM) | 138.50 M |
| 杠杆自由现金流 (LFCF TTM) | 76.74 M |
| 资产报酬率 (ROA TTM) | 8.66% |
| 股东权益报酬率 (ROE TTM) | 13.90% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | Krystal Biotech, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 4.0 |
| 内部交易活动 | NA |
| 价格波动 | 4.5 |
| 技术平均移动指标 | 5.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 3.88 |
|
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 12.21% |
| 机构持股比例 | 104.11% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 240.00 (HC Wainwright & Co., 67.05%) | 购买 |
| 中 | 190.00 (32.25%) | |
| 低 | 155.00 (Citigroup, 7.89%) | 保留 |
| 平均值 | 198.60 (38.23%) | |
| 总计 | 4 购买, 1 保留 | |
| 平均价格@调整类型 | 138.31 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Clear Street | 01 Jul 2025 | 190.00 (32.25%) | 购买 | 143.67 |
| HC Wainwright & Co. | 24 Jun 2025 | 240.00 (67.05%) | 购买 | 143.67 |
| 06 May 2025 | 240.00 (67.05%) | 购买 | 139.47 | |
| Citigroup | 16 May 2025 | 155.00 (7.89%) | 保留 | 130.60 |
| Chardan Capital | 07 May 2025 | 219.00 (52.43%) | 购买 | 136.80 |
| Guggenheim | 07 May 2025 | 189.00 (31.55%) | 购买 | 136.80 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合